MoonLake Immunotherapeutics (MLTX)

• Market cap: $624M
• 1 day: -2.48%
• 5 days: 9.11%
• 1 month: 57.12%
• 3 months: -81.97%
• 6 months: -74.92%
• Year to date: -81.67%
• 1 year: -79.56%
• 5 years: -3.44%
• 10 years: -6.39%
• Sector: Healthcare
• Industry: Biotechnology

About: MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Employees: 100